AbCellera Biologics Inc. (ABCL)

Last Closing Price: 10.47 (2026-11-19)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

AbCellera Biologics Inc. (ABCL) had Earnings per Share (EPS) (Diluted) of $-0.13 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$10.64M
$-40.76M
--
$10.64M
$63.95M
$-53.31M
$10.50M
$-42.81M
$-42.81M
$-40.76M
$-40.76M
$-40.76M
$-40.76M
$-53.31M
$-44.70M
318.05M
318.05M
$-0.13
Earnings per Share (EPS) (Diluted)
$-0.13
Balance Sheet Financials
$876.16M
$410.05M
$623.71M
$1.50B
$70.47M
--
$366.89M
$437.36M
$1.06B
$976.30M
$1.06B
326.33M
Cash Flow Statement Financials
$19.31M
$-197.18M
$214.22M
$155.25M
$190.76M
$35.51M
$35.97M
--
--
Fundamental Metrics & Ratios
12.43
--
--
--
--
100.00%
-501.13%
-501.13%
--
-402.41%
-383.10%
$11.74M
--
--
--
0.01
--
0.59
151.97
-3.84%
-4.17%
-2.72%
-3.84%
$3.26
$0.04
$0.06